MD Anderson, Cayman Chemical, and Fannin Innovation Studio form therapeutics company
ACF Pharmaceuticals to explore the potential of novel, small molecule anti-cancer agents
MD Anderson News Release 09/15/2015
The University of Texas MD Anderson Cancer Center, Cayman Chemical and Fannin Innovation Studio have formed ACF Pharmaceuticals, LLC. The pre-clinical therapeutics company is dedicated to discovering and developing novel small molecule inhibitors for the treatment of a variety of inflammation-induced...
MD Anderson to host evening fun run supporting skin cancer research
MD Anderson News Release 08/26/2015
Runners and walkers will soon hit the streets for the eighth annual AIM for the CURE Melanoma...
Moon Shots Program researchers to contribute to new Stand Up to Cancer Dream Teams
MD Anderson experts chosen for collaborative efforts against lung, ovarian cancer
MD Anderson News Release 04/20/2015
<...
Banner MD Anderson Cancer Center Opens
State-of-the-art facility is housed on the Banner Gateway campus
MD Anderson News Release 09/26/11
Banner MD Anderson Cancer Center, a unique collaboration between Banner Health and The University of Texas MD Anderson Cancer Center, opens today, ushering in a new era of unprecedented cancer care in Arizona. Banner MD Anderson joins Arizona's leading health care provider with the nation's leading...